Global News

UC San Diego initiates Cal-BRAIN program

Wednesday, June 25, 2014 01:55 PM

The California budget signed by Gov. Jerry Brown on June 20 created a statewide research grants program called Cal-BRAIN, an initiative led by UC San Diego. With an initial allocation of $2 million, Cal-BRAIN—short for California Blueprint for Research to Advance Innovations in Neuroscience—is a state complement to the federal BRAIN Initiative announced by President Barack Obama in April 2013. It aims to accelerate the development of brain mapping techniques, including the development of new technologies.

More... »

WIRB Copernicus Group

InVivo Therapeutics realigns R&D strategy

Wednesday, June 25, 2014 01:54 PM

As a result of an in-depth review of the company's R&D portfolio, InVivo Therapeutics is realigning resources behind its novel Neuro-Spinal Scaffold and the Neuro-Spinal Scaffold Plus Stem Cells program for spinal cord injury (SCI).

More... »

CRF Health eCOA webinar series

Endo to acquire Dava Pharmaceuticals

Wednesday, June 25, 2014 01:50 PM

Endo International has reached a definitive agreement to acquire Dava Pharmaceuticals, a privately held company specializing in marketed, pre-launch and pipeline generic pharmaceuticals, for $575 million in cash, with additional cash consideration of up to $25 million contingent on the achievement of certain sales milestones. The acquisition enhances Endo's commercialization and development platform and is expected to be immediately accretive to Endo's 2014 adjusted earnings per share (EPS).

More... »

Bionomics, Merck enter research collaboration

Wednesday, June 25, 2014 01:47 PM

Bionomics has entered into an exclusive research collaboration and license agreement with Merck for its BNC375 research program targeting cognitive dysfunction associated with Alzheimer's disease and other central nervous system conditions.  

More... »

Dart Therapeutics changes name to Akashi Therapeutics

Wednesday, June 25, 2014 01:46 PM

Dart Therapeutics has changed its name to Akashi Therapeutics to reflect its progress in developing a pipeline of product candidates to improve the lives of children with Duchenne muscular dystrophy (DMD).

More... »

Quintiles, Modern Marketing Concepts launch marketing analytics platform

Monday, June 23, 2014 03:46 PM

Quintiles and Modern Marketing Concepts (MMC) have launched a new marketing analytics platform that enables Quintiles to optimize sales and marketing efforts on behalf of its U.S. commercialization customers. Quintiles and MMC combine proprietary channel preference data with the innovative Next Action Marketing platform to create optimized physician communication strategies that align with their preferences and behaviors.

More... »

Parexel launches new version of Clinphone RTSM Services

Monday, June 23, 2014 03:45 PM

CRO Parexel International has launched a new version of its industry standard ClinPhone randomization and trial supply management (RTSM) services designed to help clients start clinical trials more quickly. The RTSM solution has been used in more than 3,000 studies involving over 400,000 sites and two million patients since 1993. Developed by Parexel Informatics, it is a key component of the Perceptive MyTrials platform, an integrated suite of applications for managing clinical trials.

More... »

Global Care Initiative looks to Boston for U.S. life science research partners

Monday, June 23, 2014 01:36 PM

Global Care Initiative(GCI), a consortium of five nonprofit French research institutes, intends to have a representative in Boston, Mass., as it expands in search of U.S. life science research partners.

More... »

Covance launches MarketPlace for biopharmaceutical development

Monday, June 23, 2014 01:36 PM

CRO Covance has introduced Covance MarketPlace, a new solution that enables Covance’s emerging biotechnology and established pharmaceutical clients to easily find and forge new partnerships in a secure forum.

More... »

CROs Simbec Research, Orion merge

Monday, June 23, 2014 01:34 PM

Simbec Research, a specialist CRO in early stage clinical development, and Orion, a specialist CRO in late stage clinical development, have merged. Following closing, the group will be known as Simbec-Orion Group, and both the Simbec and Orion brands will continue in their respective fields.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs